Roth Capital analyst Richard Baldry lowered the firm’s price target on Synchronoss (SNCR) to $10 from $13 and keeps a Buy rating on the shares. The company’s streamlined operations and elevated EBITDA levels of 2024 have been largely defended in 2025, with Q3 EBITDA of $12.0M only marginally below the $12.7M average of the prior six quarters, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNCR: